New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
March 1, 2023 - Prasco launched an authorized brand alternative of GSK’s Advair HFA (fluticasone/salmeterol) inhalation aerosol.
Download PDF
Return to publications
